Redi Kasollja is an experienced legal professional specializing in the biotechnology and healthcare sectors. Currently serving as Director of Value, Access & Policy Counsel and Director of Commercial Counsel at Apellis Pharmaceuticals since August 2022, Redi provides legal guidance to commercial and medical affairs teams, focusing on compliance, advertising, and promotional activities. Prior roles include Senior Director at Dyne Therapeutics, where Redi advised on regulatory compliance for oligonucleotide therapies, and Director at Thermo Fisher Scientific, offering counsel for gene and cell therapy manufacturing. Earlier experience includes positions at Foley & Lardner LLP, K&L Gates, and Flynn Wirkus Young, P.C., with a strong background in healthcare fraud litigation and regulatory issues. Redi holds a JD (cum laude) from Suffolk University Law School and a BA in Economics from Boston University.
This person is not in any offices